Descripción de la empresa
Molina Healthcare, Inc. operates as a provider of managed healthcare services, primarily serving low-income families and individuals enrolled in the Medicaid and Medicare programs, as well as participants in state insurance marketplaces within the United States. The company functions within the broader Healthcare sector, specifically the Healthcare Plans industry, positioning it as a key participant in government-sponsored and subsidized health coverage markets. Molina Healthcare maintains a substantial scale with a market capitalization of $6.98B and annual revenue reaching $43.56B, supported by a workforce of 19,000 employees. These financial figures indicate a significant operational footprint, reflecting the company's established presence in delivering essential healthcare services to vulnerable populations across multiple states.
Salud financiera
The company reported a Total Revenue of $43.56B over the trailing twelve months, generating a Net Income of $472.00M and an EBITDA of $902.00M during the same period. The substantial gap between the reported revenue and net income reveals a cost structure where expenses, including cost of goods sold and operating costs, absorb the majority of gross inflows before reaching the bottom line. Free Cash Flow stands at -$100,000,000, indicating that capital expenditures and operational cash outflows currently exceed cash generated from operations, which limits immediate financial flexibility for large-scale acquisitions without external financing. Profitability is analyzed through three key margins: a Gross Margin of 9.4%, an Operating Margin of -1.5%, and a Profit Margin of 1.1%. The negative operating margin suggests that operating expenses are currently exceeding operating income, while the positive profit margin indicates that non-operating factors or tax advantages are contributing to overall net income. The balance sheet shows a Cash position of $8.26B against Total Debt of $4.05B, with a Debt to Equity ratio of 99.44, presenting a highly leveraged financial structure where debt significantly outweighs equity. Despite the high leverage, the Current Ratio of 1.69 indicates a healthy short-term liquidity position, ensuring the company can cover its current liabilities with its current assets. Return on Equity is measured at 11.0% while Return on Assets is 3.1%, metrics that reveal the efficiency of management in generating profits relative to shareholder equity and total assets respectively.
Evaluación de valoración
Valuation metrics include a Trailing Twelve Months P/E Ratio of 15.01 and a Forward P/E of 15.47, suggesting a slight expansion in expected earnings trajectory implied by the forward multiple relative to the trailing figure. The Price to Book ratio is 1.68, which indicates that the market values the company at a premium of 68% over its tangible book value. Alternative valuation measures such as the Price to Sales ratio of 0.16 and an EV/EBITDA of 2.98 suggest the stock is priced at a fraction of its sales, while the low EV/EBITDA multiple reflects the high debt load inherent in the business model. The stock price has fluctuated between a 52-Week High of $359.97 and a 52-Week Low of $121.06, placing the current trading level significantly below the recent peak and providing context for recent price volatility. The Beta value of 0.50 indicates that the stock exhibits lower price volatility than the broader market, moving with approximately half the intensity of the S&P 500 index during market swings.
Growth & Income
Revenue Growth year-over-year is recorded at 7.1%, whereas Earnings Growth is listed as N/A, preventing a direct comparison of earnings expansion versus revenue expansion but highlighting the challenges in translating top-line growth into proportional bottom-line increases. The company does not pay a dividend, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning the company retains all earnings rather than distributing them to shareholders. This retention strategy implies that the company prioritizes reinvesting cash flows into operational growth, debt reduction, or other capital allocation strategies rather than income generation for investors. The overall growth and income profile is characterized by solid double-digit revenue expansion and a disciplined approach to capital distribution through zero dividends, though the lack of reported earnings growth data limits insight into the efficiency of that reinvestment.
Comparación con pares
Molina Healthcare, Inc. (MOH) opera en la industria de Planes de Salud. Así se compara con sus pares más cercanos por capitalización de mercado:
El ratio P/E promedio de la industria Planes de Salud es 45.1x. Molina Healthcare, Inc. cotiza a un P/E de 49.2.